-
FDA Patient-Focused Drug Development (PFDD) Guidance - Part 3
Jul 5, 2023, 09:26 AM -
Assessment of Digital Health Technologies in the Asia Pacific Region
Jun 9, 2023, 09:48 AM -
Challenges in Rare Disease Diagnostics: An Overview
Jun 5, 2023, 15:35 PM -
Clinical Trial Innovation: How Healthcare Technology is Evolving
Jun 1, 2023, 09:44 AM -
Introduction to Open-Source Modeling: R We There Yet?
Apr 23, 2023, 15:45 PM -
Health Equity in HEOR: Past, Present & Future Research Implications
Apr 5, 2023, 08:00 AM -
FDA Patient-Focused Drug Development (PFDD) Guidance - Part 2
Mar 8, 2023, 13:22 PM -
Improving Treatment Access and Outcomes by Integrating Social Determinants of Health Data With Real-World Evidence
Feb 23, 2023, 15:45 PM -
Preventing, Detecting, and Analyzing Data From Suspected Fraudulent Respondents in Online Surveys, with Examples From Health Preference Studies
Feb 17, 2023, 10:47 AM -
Digital Endpoint Adoption: the How, What and Why
Feb 10, 2023, 12:54 PM -
FDA Patient-Focused Drug Development (PFDD) Guidance - Part 1
Feb 7, 2023, 12:48 PM -
Achieving Fit for Purpose Data from Wearables for Age-Related Diseases
Jan 13, 2023, 15:25 PM -
Strategies and Skills to Land Your First Job: The Interview
Dec 13, 2022, 13:01 PM -
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making
Dec 6, 2022, 13:41 PM -
Different HTA Perspectives on Reliably Estimating Treatment Effects
Nov 16, 2022, 11:02 AM -
Actualización de Política de Salud: ISPOR América Latina
Nov 15, 2022, 09:46 AM -
Can the Benefits From Biosimilars Be Sustainably Increased? Policy Recommendations for Europe, Middle East and Canada
Oct 20, 2022, 10:44 AM -
Oportunidades de carrera en HEOR para América Latina | Career Opportunities in HEOR in Latin America
Oct 13, 2022, 18:21 PM -
Health Insurance in Africa: Sustainability in Focus
Oct 11, 2022, 10:03 AM -
Availability and Access to Innovative Therapies in Latin America
Oct 6, 2022, 19:11 PM